New pill shows promise in shrinking liver fat in NASH patients
NCT ID NCT02912260
First seen Jan 11, 2026 · Last updated Jun 17, 2026 · Updated 29 times
Summary
This study tested an oral drug called MGL-3196 in 125 adults with NASH, a serious liver disease. The main goal was to see if the drug could reduce liver fat measured by MRI after 12 weeks, compared to a placebo. Results suggest the drug may help control the disease, but long-term management is still needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC STEATOHEPATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Madrigal Research Site
Dothan, Alabama, United States
-
Madrigal Research Site
Tucson, Arizona, United States
-
Madrigal Research Site
Coronado, California, United States
-
Madrigal Research Site
Los Angeles, California, 90057, United States
-
Madrigal Research Site
Rialto, California, United States
-
Madrigal Research Site
San Diego, California, United States
-
Madrigal Research Site
Ventura, California, United States
-
Madrigal Research Site
Englewood, Colorado, United States
-
Madrigal Research Site
Boca Raton, Florida, United States
-
Madrigal Research Site
Lakewood Rch, Florida, United States
-
Madrigal Research Site
Lauderdale Lakes, Florida, United States
-
Madrigal Research Site
Miami, Florida, United States
-
Madrigal Research Site
New Port Richey, Florida, United States
-
Madrigal Research Site
Kansas City, Kansas, United States
-
Madrigal Research Site
Monroe, Louisiana, United States
-
Madrigal Research Site
Baltimore, Maryland, United States
-
Madrigal Research Site
Jackson, Mississippi, 39202, United States
-
Madrigal Research Site
St Louis, Missouri, United States
-
Madrigal Research Site
Albuquerque, New Mexico, United States
-
Madrigal Research Site
New York, New York, United States
-
Madrigal Research Site
Durham, North Carolina, United States
-
Madrigal Research Site
Rapid City, South Dakota, United States
-
Madrigal Research Site
Live Oak, Texas, 78233, United States
-
Madrigal Research Site
San Antonio, Texas, United States
-
Madrigal Research Site
Charlottesville, Virginia, United States
-
Madrigal Research Site
Seattle, Washington, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.